1. Home
  2. PCYO vs CLLS Comparison

PCYO vs CLLS Comparison

Compare PCYO & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCYO
  • CLLS
  • Stock Information
  • Founded
  • PCYO 1976
  • CLLS 1999
  • Country
  • PCYO United States
  • CLLS France
  • Employees
  • PCYO N/A
  • CLLS N/A
  • Industry
  • PCYO Water Supply
  • CLLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCYO Utilities
  • CLLS Health Care
  • Exchange
  • PCYO Nasdaq
  • CLLS Nasdaq
  • Market Cap
  • PCYO 254.1M
  • CLLS 240.2M
  • IPO Year
  • PCYO N/A
  • CLLS 2007
  • Fundamental
  • Price
  • PCYO $10.80
  • CLLS $2.01
  • Analyst Decision
  • PCYO
  • CLLS Buy
  • Analyst Count
  • PCYO 0
  • CLLS 2
  • Target Price
  • PCYO N/A
  • CLLS $8.00
  • AVG Volume (30 Days)
  • PCYO 42.0K
  • CLLS 22.9K
  • Earning Date
  • PCYO 11-13-2024
  • CLLS 11-04-2024
  • Dividend Yield
  • PCYO N/A
  • CLLS N/A
  • EPS Growth
  • PCYO N/A
  • CLLS N/A
  • EPS
  • PCYO 0.25
  • CLLS N/A
  • Revenue
  • PCYO $19,555,000.00
  • CLLS $19,635,000.00
  • Revenue This Year
  • PCYO N/A
  • CLLS $271.02
  • Revenue Next Year
  • PCYO N/A
  • CLLS $33.48
  • P/E Ratio
  • PCYO $43.19
  • CLLS N/A
  • Revenue Growth
  • PCYO N/A
  • CLLS N/A
  • 52 Week Low
  • PCYO $8.94
  • CLLS $0.96
  • 52 Week High
  • PCYO $11.32
  • CLLS $3.77
  • Technical
  • Relative Strength Index (RSI)
  • PCYO 56.24
  • CLLS 41.74
  • Support Level
  • PCYO $10.48
  • CLLS $1.95
  • Resistance Level
  • PCYO $10.86
  • CLLS $2.06
  • Average True Range (ATR)
  • PCYO 0.26
  • CLLS 0.10
  • MACD
  • PCYO -0.02
  • CLLS -0.01
  • Stochastic Oscillator
  • PCYO 68.47
  • CLLS 33.33

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

Share on Social Networks: